GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allegra Medical Technologies Ltd (ASX:AMT) » Definitions » Gross Profit

Allegra Medical Technologies (ASX:AMT) Gross Profit : A$-0.54 Mil (TTM As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Allegra Medical Technologies Gross Profit?

Allegra Medical Technologies's gross profit for the six months ended in Dec. 2023 was A$0.24 Mil. Allegra Medical Technologies's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.54 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Allegra Medical Technologies's gross profit for the six months ended in Dec. 2023 was A$0.24 Mil. Allegra Medical Technologies's Revenue for the six months ended in Dec. 2023 was A$0.48 Mil. Therefore, Allegra Medical Technologies's Gross Margin % for the quarter that ended in Dec. 2023 was 49.38%.

Allegra Medical Technologies had a gross margin of 49.38% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Allegra Medical Technologies was 66.61%. The lowest was -111.67%. And the median was 57.17%.


Allegra Medical Technologies Gross Profit Historical Data

The historical data trend for Allegra Medical Technologies's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allegra Medical Technologies Gross Profit Chart

Allegra Medical Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.19 2.82 2.47 1.20 -0.01

Allegra Medical Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.42 0.76 -0.77 0.24

Competitive Comparison of Allegra Medical Technologies's Gross Profit

For the Medical Devices subindustry, Allegra Medical Technologies's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allegra Medical Technologies's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allegra Medical Technologies's Gross Profit distribution charts can be found below:

* The bar in red indicates where Allegra Medical Technologies's Gross Profit falls into.



Allegra Medical Technologies Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Allegra Medical Technologies's Gross Profit for the fiscal year that ended in Jun. 2023 is calculated as

Gross Profit (A: Jun. 2023 )=Revenue - Cost of Goods Sold
=0 - 0.014
=-0.01

Allegra Medical Technologies's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=0.48 - 0.243
=0.24

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.54 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Allegra Medical Technologies's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.24 / 0.48
=49.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Allegra Medical Technologies  (ASX:AMT) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Allegra Medical Technologies had a gross margin of 49.38% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Allegra Medical Technologies Gross Profit Related Terms

Thank you for viewing the detailed overview of Allegra Medical Technologies's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Allegra Medical Technologies (ASX:AMT) Business Description

Traded in Other Exchanges
N/A
Address
18-20 Orion Road, Level 8, Lane Cove West, Sydney, NSW, AUS, 2066
Allegra Medical Technologies Ltd is engaged in the research, product development, and manufacturing of medical devices including prosthetic implant tools. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip stems and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems among others. It operates in two segments Orthopaedics Division, which derives the majority of its revenue sells and distributes its portfolio of medical device products. Innovation Division which invests resources into the development and commercialization of new products to take to market.